Ketorolac Tromethamine INJECTION recall: Labeling Error
Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAGENT…
Why was Ketorolac Tromethamine INJECTION recalled?
Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot MP5021, Exp. 04/16; Lots MP5024, MP5025, Exp. 05/16
- Product
- Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAGENT…
- Recalling firm
- Sagent Pharmaceuticals Inc
- Quantity
- 69,050 vials
- Distribution
- Nationwide and Puerto Rico
- Recall date
- October 22, 2014
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)